Division of Nephrology, Faculty and Department of Medicine, CHU de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Université Laval, 11 Côte-du-Palais, Quebec City, QC, G1R2J6, Canada.
Department of Radiology, Faculty of Medicine, CHU de Québec, L'Hôtel-Dieu de Québec Hospital, Université Laval, 11 Côte-du-Palais, Quebec City, QC, G1R 2J6, Canada.
J Nephrol. 2021 Jun;34(3):901-906. doi: 10.1007/s40620-020-00798-x. Epub 2020 Jul 12.
Chronic kidney disease-mineral and bone disorder (CKD-MBD) leads to increased fracture risk. Iliac crest biopsy remains the gold standard for diagnosing bone disease in CKD. Unfortunately, bone biopsy is rarely performed which is mainly due to the inability of clinicians to perform the procedure. In this paper, we propose a fluoroscopy-guided procedure performed by interventional radiologists as a novel approach to iliac crest biopsy in adult population. We describe the implementation of the procedure and present the first 11 cases of CKD patients who underwent iliac crest biopsy with this new approach.
A nephrologist already trained in performing iliac crest biopsy initiated the creation of a fluoroscopy-based iliac crest biopsy program. Two interventional radiologists underwent a short training. Patients' demographical, clinical and biochemical data were collected on the day of the biopsy. Complications within the first three months after the procedure were collected from electronical records.
IR rapidly mastered the procedure. The use of fluoroscopy allowed a precise localisation of the biopsy site and standardization of the intervention, which ensured specimen quality. The new approach allowed CKD patients to access iliac crest biopsy, which resulted in precise bone disease diagnosis (levels of bone turnover and mineralization) and targeted therapy for each case. There were no complications during, nor within 3 months after the intervention.
We believe this approach will increase the access to iliac crest biopsy for diagnosing bone disease in CKD population. Studies are now needed to evaluate whether CKD patients will benefit from anti-osteoporotic therapy based on the results of iliac crest biopsy.
慢性肾脏病-矿物质和骨异常(CKD-MBD)可导致骨折风险增加。髂嵴活检仍然是诊断 CKD 患者骨骼疾病的金标准。不幸的是,很少进行骨活检,主要是因为临床医生无法进行该操作。本文提出了一种由介入放射科医生进行的透视引导下的髂嵴活检程序,作为一种诊断成人 CKD 患者骨骼疾病的新方法。我们描述了该程序的实施过程,并介绍了首例 11 例接受该新方法髂嵴活检的 CKD 患者的情况。
已经接受过髂嵴活检培训的肾脏病医生启动了透视引导下的髂嵴活检项目。两名介入放射科医生接受了短期培训。在活检当天收集患者的人口统计学、临床和生化数据。从电子记录中收集术后 3 个月内的并发症。
IR 迅速掌握了该操作。透视的使用可以精确地定位活检部位,并使干预标准化,从而确保标本质量。这种新方法使 CKD 患者能够进行髂嵴活检,从而对每位患者进行了精确的骨骼疾病诊断(骨转换和矿化水平)和靶向治疗。在操作过程中和操作后 3 个月内均无并发症。
我们相信这种方法将增加 CKD 患者进行髂嵴活检的机会,以诊断骨骼疾病。现在需要研究来评估 CKD 患者是否会从基于髂嵴活检结果的抗骨质疏松治疗中受益。